Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis
Abstract
Developing safe and efficient non-viral delivery systems remains a major challenge for in vivo applications of gene therapy, especially in cystic fibrosis. Unlike conventional cationic polymers or lipids, the emerging poloxamine-based copolymers display promising in vivo gene delivery capabilities. However, poloxamines are invalid for in vitro applications and their in vivo transfection efficiency is still low compared with viral vectors. Here, we show that peptides developed by modular design approaches can spontaneously form compact and monodisperse nanoparticles with poloxamines and nucleic acids via self-assembly. Both messenger RNA and plasmid DNA expression mediated by peptide-poloxamine nanoparticles are greatly boosted in vitro and in the lungs of cystic fibrosis mice with negligible toxicity. Peptide-poloxamine nanoparticles containing integrating vectors enable successful in vitro and in vivo long-term restoration of cystic fibrosis transmembrane conductance regulator deficiency with a safe integration profile. Our dataset provides a new framework for designing non-viral gene delivery systems qualified for in vivo genetic modifications.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
After three-time i.t. administration of peptide-poloxamine nanoparticles containing the Sleeping Beauty transposon system, CFTR expression lasted for 18 weeks in CF mice and the level was similar to that of the wild type group.
“After three-time i.t. administration, CFTR expression lasted for 18 weeks in CF mice and the level was similar to that of the wild type group.”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [45]
Lung pathohistological sections indicated no visible signs of inflammatory infiltrates and blood sample analysis showed a normal level of white blood cells after treatment.
“Meanwhile, lung pathohistological sections indicated no visible signs of inflammatory infiltrates and blood sample analysis showed a normal level of white blood cells.[45]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [45]
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · see citing works
Webb, A. K. (2006) · Cited by 4,369 · see citing works
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · see citing works
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O’Riordan, C. R., & Smith, A. E. (1990) · Cell · doi:10.1016/0092-8674(90)90148-8 · Cited by 1,792 · see citing works
Elborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,710 · see citing works
Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460 · see citing works
Schwank, G., Koo, B.-K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C. K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.002 · Cited by 1,424 · see citing works
Therapeutic genome editing: prospects and challenges
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336 · see citing works
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139 · see citing works
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Dekkers, J. F., Wiegerinck, C. L., de Jonge, H. R., Bronsveld, I., Janssens, H. M., de Winter-de Groot, K. M., Brandsma, A. M., de Jong, N. W. M., Bijvelds, M. J. C., Scholte, B. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3201 · Cited by 999 · see citing works
In vitro and ex vivo strategies for intracellular delivery
Stewart, M. P., Sharei, A., Ding, X., Sahay, G., Langer, R., & Jensen, K. F. (2016) · Nature · doi:10.1038/nature19764 · Cited by 885 · see citing works
Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs
Rogers, C. S., Stoltz, D. A., Meyerholz, D. K., Ostedgaard, L. S., Rokhlina, T., Taft, P. J., Rogan, M. P., Pezzulo, A. A., Karp, P. H., Itani, O. A., et al. (2008) · Science · doi:10.1126/science.1163600 · Cited by 752 · see citing works
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733 · see citing works
Self-citationOrigins of Cystic Fibrosis Lung Disease
Stoltz, D. A., Meyerholz, D. K., & Welsh, M. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300109 · Cited by 669 · see citing works
Delivery technologies for genome editing
Yin, H., Kauffman, K. J., & Anderson, D. G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.280 · Cited by 597 · see citing works
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
Dahlman, J. E., Barnes, C., Khan, O. F., Thiriot, A., Jhunjhunwala, S., Shaw, T. E., Xing, Y., Sager, H. B., Sahay, G., Speciner, L., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.84 · Cited by 593 · see citing works
PEGylation for enhancing nanoparticle diffusion in mucus
Huckaby, J. T., & Lai, S. K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.010 · Cited by 470 · see citing works
Alton, E. W. F. W., Armstrong, D. K., Ashby, D., Bayfield, K. J., Bilton, D., Bloomfield, E. V., Boyd, A. C., Brand, J., Buchan, R., Calcedo, R., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00245-3 · Cited by 428 · see citing works
Suk, J. S., Lai, S. K., Wang, Y.-Y., Ensign, L. M., Zeitlin, P. L., Boyle, M., & Hanes, J. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.076 · Cited by 355 · see citing works
Konstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1255 · Cited by 298 · see citing works
Moss, R. B., Milla, C. E., Colombo, J. L., Accurso, F. J., Zeitlin, P. L., Clancy, J. P., Spencer, L. T., Pilewski, J. M., Waltz, D. A., Dorkin, H. L., et al. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.022 · Cited by 276 · see citing works
Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus
Yang, M., Lai, S. K., Wang, Y., Zhong, W., Happe, C., Zhang, M., Fu, J., & Hanes, J. S. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006849 · Cited by 262 · see citing works
Kreda, S. M., Mall, M. A., Mengos, A. E., Rochelle, L. G., Yankaskas, J. R., Riordan, J. R., & Boucher, R. C. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1010 · Cited by 249 · see citing works
Mastorakos, P., da Silva, A. L., Chisholm, J., Song, E., Choi, W. K., Boyle, M. P., Morales, M. M., Hanes, J., & Suk, J. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502281112 · Cited by 210 · see citing works
Nafee, N., Husari, A., Maurer, C. K., Lu, C., de Rossi, C., Steinbach, A., Hartmann, R. W., Lehr, C.-M., & Schneider, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.055 · Cited by 208 · see citing works
Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier
Suk, J. S., Kim, A. J., Trehan, K., Schneider, C. S., Cebotaru, L., Woodward, O. M., Boylan, N. J., Boyle, M., Lai, S. K., Guggino, W. B., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.01.007 · Cited by 193 · see citing works
Large‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver
Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3606-3614.2005 · Cited by 190 · see citing works
The Mucus Barrier to Inhaled Gene Therapy
Duncan, G. A., Jung, J., Hanes, J. S., & Suk, J. S. (2016) · Molecular Therapy · doi:10.1038/mt.2016.182 · Cited by 190 · see citing works
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Alton, E. W. F. W., Beekman, J. M., Boyd, A. C., Brand, J., Carlon, M. S., Connolly, M. M., Chan, M., Conlon, S., Davidson, H. E., Davies, J. C., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208406 · Cited by 150 · see citing works
McNeer, N. A., Anandalingam, K. K., Fields, R. J., Caputo, C. R., Kopic, S., Gupta, A., Quijano, E., Polikoff, L. A., Kong, Y., Bahal, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7952 · Cited by 139 · see citing works
Gene Therapy with the Sleeping Beauty Transposon System
Kebriaei, P., Izsvák, Z., Narayanavari, S. A., Singh, H., & Ivics, Z. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.08.008 · Cited by 124 · see citing works
Barriers to inhaled gene therapy of obstructive lung diseases: A review
Kim, N., Duncan, G. A., Hanes, J. S., & Suk, J. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.031 · Cited by 118 · see citing works
Animal and model systems for studying cystic fibrosis
Rosen, B. H., Chanson, M., Gawenis, L. R., Liu, J., Sofoluwe, A., Zoso, A., & Engelhardt, J. F. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.09.001 · Cited by 106 · see citing works
Joseph, P. M., O'Sullivan, B. P., Lapey, A., Dorkin, H. L., Oren, J., Balfour, R., Perricone, M. A., Rosenberg, M., Wadsworth, S. C., Smith, A. E., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750298535 · Cited by 101 · see citing works
Poloxamine-based nanomaterials for drug delivery
Alvarez‐Lorenzo, C. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e102 · Cited by 99 · see citing works
Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer
Pitard, B. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh153 · Cited by 89 · see citing works
Preclinical and clinical advances in transposon-based gene therapy
Tipanee, J., Chai, Y. C., VandenDriessche, T., & Chuah, M. (2017) · Bioscience Reports · doi:10.1042/bsr20160614 · Cited by 89 · see citing works
Lee, C. M., Flynn, R., Hollywood, J. A., Scallan, M. F., & Harrison, P. T. (2012) · BioResearch open access · doi:10.1089/biores.2012.0218 · Cited by 84 · see citing works
Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery
Tagalakis, A. D., He, L., Saraiva, L., Gustafsson, K. T., & Hart, S. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.022 · Cited by 84 · see citing works
Retargeting Sleeping Beauty Transposon Insertions by Engineered Zinc Finger DNA-binding Domains
Voigt, K., Gogol‐Döring, A., Miskey, C., Chen, W., Cathomen, T., Izsvák, Z., & Ivics, Z. (2012) · Molecular Therapy · doi:10.1038/mt.2012.126 · Cited by 63 · see citing works
Zeng, J., Wang, X., & Wang, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.015 · Cited by 57 · see citing works
Writer, M. J., Marshall, B. J., Pilkington‐Miksa, M. A., Barker, S. E., Jacobsen, M. C., Kritz, A., Bell, P. C., Lester, D. H., Tabor, A. B., Hailes, H. C., et al. (2004) · Journal of drug targeting · doi:10.1080/10611860410001724459 · Cited by 55 · see citing works
Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier
Gioia, S. D., Trapani, A., Castellani, S., Carbone, A., Belgiovine, G., Craparo, E. F., Puglisi, G., Cavallaro, G., Trapani, G., & Conese, M. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.07.003 · Cited by 53 · see citing works
Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration
Johler, S. M., Rejman, J., Guan, S., & Rosenecker, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137504 · Cited by 46 · see citing works
Hybrid Nonviral/Viral Vector Systems for Improved piggyBac DNA Transposon In Vivo Delivery
Cooney, A. L., Singh, B. K., & Sinn, P. L. (2015) · Molecular Therapy · doi:10.1038/mt.2014.254 · Cited by 43 · see citing works
Bello-Roufai, M., Lambert, O., & Pitard, B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl860 · Cited by 42 · see citing works
Parameters affecting organization and transfection efficiency of amphiphilic copolymers/DNA carriers
Roques, C., Bouchemal, K., Ponchel, G., Fromes, Y., & Fattal, E. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.030 · Cited by 37 · see citing works
Integrating DNA Vectors For Gene Therapy
Hackett, P. B. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300065 · Cited by 36 · see citing works
Spontaneous rescue from cystic fibrosis in a mouse model
Charizopoulou, N., Wilke, M., Dorsch, M. M., Bot, A. G. M., Jorna, H., Jansen, S., Stanke, F., Hedrich, H. J., de Jonge, H. R., & Tümmler, B. (2006) · BMC Genetics · doi:10.1186/1471-2156-7-18 · Cited by 24 · see citing works
Evaluation of tetrafunctional block copolymers as synthetic vectors for lung gene transfer
Richard, P., Hervouet, C., Marsault, R., Franken, P. R., Cambien, B., Guglielmi, J., Warnez‐Soulie, J., Darcourt, J., Pourcher, T., Colombani, T., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.051 · Cited by 20 · see citing works
Specifically integrating vectors for targeted gene delivery: progress and prospects
Kovač, A., & Ivics, Z. (2017) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2017.013 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933 · see citing works
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
Lokugamage, M. P., Vanover, D. A., Beyersdorf, J. P., Hatit, M. Z. C., Rotolo, L., Echeverri, E. S., Peck, H. E., Ni, H., Yoon, J., Kim, Y., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00786-x · Cited by 507 · see citing works
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Abbott, T. R., Dhamdhere, G. R., Liu, Y., Lin, X., Goudy, L., Zeng, L., Chemparathy, A. G., Chmura, S. A., Heaton, N. S., Debs, R. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.020 · Cited by 500 · see citing works
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Suberi, A., Grun, M. K., Mao, T., Israelow, B., Reschke, M., Grundler, J., Akhtar, L., Lee, T., Shin, K., Piotrowski-Daspit, A. S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq0603 · Cited by 184 · see citing works
Loughrey, D., & Dahlman, J. E. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00601 · Cited by 173 · see citing works
Molecularly Stimuli-Responsive Self-Assembled Peptide Nanoparticles for Targeted Imaging and Therapy
Zhou, Y., Li, Q., Wu, Y., Li, X., Zhou, Y., Wang, Z., Liang, H., Ding, F., Hong, S., Steinmetz, N. F., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c01452 · Cited by 166 · see citing works
Sandoval-Villegas, N., Nurieva, W., Amberger, M., & Ivics, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105084 · Cited by 142 · see citing works
Nanomaterials for Therapeutic RNA Delivery
Han, X., Mitchell, M. J., & Nie, G. (2020) · Matter · doi:10.1016/j.matt.2020.09.020 · Cited by 137 · see citing works
Nanotechnology based therapeutics for lung disease
Doroudian, M., MacLoughlin, R. J., Poynton, F. E., Prina‐Mello, A., & Donnelly, S. C. (2019) · Thorax · doi:10.1136/thoraxjnl-2019-213037 · Cited by 127 · see citing works
Inhaled RNA Therapy: From Promise to Reality
Chow, M. Y. T., Qiu, Y., & Lam, J. K. W. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.002 · Cited by 105 · see citing works
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
Velino, C., Carella, F., Adamiano, A., Sanguinetti, M., Vitali, A., Catalucci, D., Bugli, F., & Iafisco, M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00406 · Cited by 95 · see citing works
RNA delivery biomaterials for the treatment of genetic and rare diseases
Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works
Kim, J., Ashwanikumar, N., Patel, S., & Sahay, G. (2019) · Theranostics · doi:10.7150/thno.33921 · Cited by 78 · see citing works
One‐Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells
Zhang, X., Su, K., Wu, S., Lin, L., He, S., Yan, X., Shi, L., & Liu, S. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202405444 · Cited by 75 · see citing works
Dai, J., Hu, J., Dong, X., Chen, B., Dong, X., Liu, R., Xia, F., & Lou, X. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202117798 · Cited by 75 · see citing works
tRNA therapeutics for genetic diseases
Coller, J., & Ignatova, Z. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00829-9 · Cited by 72 · see citing works
Polyethylenimine‐Based Nanogels for Biomedical Applications
Zou, Y. F., Li, D., Shen, M., & Shi, X. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900272 · Cited by 69 · see citing works
Uludağ, H., Ubeda, A., & Ansari, A. S. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00131 · Cited by 66 · see citing works
mRNA therapies: Pioneering a new era in rare genetic disease treatment
Shen, G., Liu, J., Yang, H., Xie, N., & Yang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.056 · Cited by 61 · see citing works
Recent Advances in the Noninvasive Delivery of mRNA
Qin, M., Du, G., & Sun, X. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00493 · Cited by 60 · see citing works
Feng, X., Shi, Y., Zhang, Y., Lei, F., Ren, R., & Tang, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s446919 · Cited by 66 · see citing works
Deshmukh, R., Sethi, P., Singh, B., Shiekmydeen, J., Salave, S., Patel, R. J., Ali, N., Rashid, S., Elossaily, G. M., & Kumar, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081076 · Cited by 59 · see citing works
Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
Tang, J., Cai, L., Xu, C., Sun, S., Liu, Y., Rosenecker, J., & Guan, S. (2022) · Nanomaterials · doi:10.3390/nano12020226 · Cited by 54 · see citing works
Wang, Y.-T., Yang, Y., Wang, X., Kawazoe, N., Yang, Y., & Chen, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.01.042 · Cited by 54 · see citing works
Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders
Wan, T. Y., & Yuan, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.002 · Cited by 55 · see citing works
Targeting strategies for mRNA delivery
Meyer, R. A., Neshat, S. Y., Green, J. J., Santos, J. L., & Tuesca, A. D. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100240 · Cited by 53 · see citing works
Li, X., Li, J., Wei, J., Du, W., Su, C., Shen, X., Zhao, A., & Xu, M. (2025) · MedComm · doi:10.1002/mco2.70414 · Cited by 56 · see citing works
Wu, J., Wang, Q., Dong, X., Xu, M., Yang, J., Yi, X., Chen, B., Dong, X., Wang, Y., Lou, X., et al. (2021) · Theranostics · doi:10.7150/thno.53828 · Cited by 50 · see citing works
Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies
Gaikwad, S. S., Pathare, S. R., More, M. A., Waykhinde, N. A., Laddha, U. D., Salunkhe, K. S., Kshirsagar, S. J., Patil, S. S., & Ramteke, K. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.083 · Cited by 48 · see citing works
Amberger, M., & Ivics, Z. (2020) · BioEssays · doi:10.1002/bies.202000136 · Cited by 48 · see citing works
Toy, R., Pradhan, P., Ramesh, V., Paolo, N. C. D., Lash, B., Liu, J., Blanchard, E. L., Pinelli, C. J., Santangelo, P. J., Shayakhmetov, D. M., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119512 · Cited by 46 · see citing works
Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies
Almughem, F. A., Aldossary, A. M., Tawfik, E. A., Alomary, M. N., Alharbi, W. S., Alshahrani, M. Y., & Alshehri, A. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070616 · Cited by 48 · see citing works
Polyplex designs for improving the stability and safety of RNA therapeutics
Uchida, S., Lau, C. Y. J., Oba, M., & Miyata, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114972 · Cited by 46 · see citing works
Dai, J., Dong, X., Liu, R., Chen, B., Dong, X., Wang, Q., Hu, J., Xia, F., & Lou, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121528 · Cited by 42 · see citing works
Emerging gene therapies for cystic fibrosis
Miah, K. M., Hyde, S. C., & Gill, D. R. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1634547 · Cited by 39 · see citing works
Ionizable polymeric micelles (IPMs) for efficient siRNA delivery
Zhou, Z., Yu, F., Jiang, M., Yao, Z., Wang, J., Pan, F., Feng, R., Zhao, C., Ma, Y., Zhou, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55721-w · Cited by 39 · see citing works
Advances in nanomedicine for the treatment of ankylosing spondylitis
Xi, Y., Jiang, T., Chaurasiya, B., Zhou, Y., Yu, J., Wen, J., Shen, Y., Ye, X., & Webster, T. J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s216199 · Cited by 40 · see citing works
Cystic fibrosis: new challenges and perspectives beyond elexacaftor/tezacaftor/ivacaftor
Terlizzi, V., & Lopes‐Pacheco, M. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251323194 · Cited by 34 · see citing works
Le, Z., Pan, Q., He, Z., Liu, H., Shi, Y., Liu, L., Liu, Z., Yuan, P., & Chen, Y. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00207 · Cited by 32 · see citing works
Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery
Zeng, G., He, Z., Yang, H., Gao, Z., Ge, X., Liu, L., Liu, Z., & Chen, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c02415 · Cited by 30 · see citing works
Sun, D., Li, Y., Yin, X., Fan, Y., Liu, J., Wang, Y., Liu, X., Bai, G., Li, K., Shi, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c11412 · Cited by 28 · see citing works
Cao, H., Ouyang, H., Laselva, O., Bartlett, C., Zhou, Z. P., Duan, C., Gunawardena, T. N. A., Avolio, J., Bear, C. E., Gonska, T. Y., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00205-2020 · Cited by 27 · see citing works
Zhao, J., Lu, D., Moya, S. E., Yan, H., Qiu, M., Chen, J., Wang, X., Li, Y., Pan, H., Chen, G., et al. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100701 · Cited by 28 · see citing works
Wang, Q., Bu, C., Dai, Q., Chen, J., Zhang, R., Zheng, X., Ren, H., Xin, X., & Li, X. (2024) · Advanced Science · doi:10.1002/advs.202309748 · Cited by 27 · see citing works
Jiang, K., Fan, X., Hu, Y., Yao, S.-Y., Liu, Y., Zhan, C., Lu, W., & Wei, G. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121493 · Cited by 27 · see citing works
Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations
Wang, Y., Hu, L., Zhou, T., Qi, L., Xing, L., Lee, J., Wang, F., Oh, Y., & Jiang, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121108 · Cited by 24 · see citing works
Sun, S., Li, E., Zhao, G., Tang, J., Zuo, Q., Cai, L., Xu, C., Sui, C., Ou, Y., Liu, C., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121907 · Cited by 22 · see citing works
Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung
de Braganca, L., Ferguson, G. J., Santos, J. L., & Derrick, J. P. (2021) · Journal of Immunotoxicology · doi:10.1080/1547691x.2021.1902432 · Cited by 23 · see citing works
Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases
Huang, Y., Zhang, J., Wang, X., Jing, H., & Li, H. (2024) · Biomolecules · doi:10.3390/biom14080904 · Cited by 20 · see citing works
Peptide-based nanomaterials for gene therapy
Zhang, W., Chen, Q., Wu, F., Dai, J., Ding, D., Wu, J., Lou, X., & Xia, F. (2020) · Nanoscale Advances · doi:10.1039/d0na00899k · Cited by 19 · see citing works
Peptide-based Nanomaterials: Self-assembly and Applications
Zou, Q., Jin, Y., Tan, L., Ren, H., Wu, L. F., Bao, Y., & Chen, Y. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220819103907 · Cited by 19 · see citing works
Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression
Zadory, M., Lopez, E., Babity, S., Gravel, S., & Brambilla, D. (2022) · Biomaterials Science · doi:10.1039/d2bm00859a · Cited by 18 · see citing works
Sharma, D., Dhiman, I., Paul, S. D., Das, D. K., Das, D., Dash, S. K., & Pramanik, A. (2025) · ACS Omega · doi:10.1021/acsomega.5c02077 · Cited by 18 · see citing works
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?
Oliver, K. E., Carlon, M. S., Pedemonte, N., & Lopes‐Pacheco, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2230129 · Cited by 18 · see citing works
Inhaled non-viral delivery systems for RNA therapeutics
Huang, C., Li, H., Duan, X., Zhang, P., Qi, S., Du, J., Song, X., Tong, A., & Yu, G. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.033 · Cited by 21 · see citing works
Rosenecker, J., Guan, S., Darmstädter, M., & Xu, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081281 · Cited by 15 · see citing works
One‐Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells
Zhang, X., Su, K., Wu, S., Lin, L., He, S., Yan, X., Shi, L., & Liu, S. (2024) · Angewandte Chemie · doi:10.1002/ange.202405444 · Cited by 16 · see citing works
Rewriting CFTR to cure cystic fibrosis
Maule, G., Ensinck, M. M., Bulcaen, M., & Carlon, M. S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.018 · Cited by 16 · see citing works
Chang, L., Yan, H., Chang, J., & Gautrot, J. E. (2021) · European Polymer Journal · doi:10.1016/j.eurpolymj.2021.110593 · Cited by 16 · see citing works
Costa, B., Boueri, B., Oliveira, C. L., Silveira, I., & Ribeiro, A. J. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2075846 · Cited by 16 · see citing works
Liu, C., Tian, X., Wang, Z., Mak, J., Mao, S., Liu, T., & Zheng, Y. (2025) · Science Advances · doi:10.1126/sciadv.adt2752 · Cited by 15 · see citing works
Gene Therapy: Towards a New Era of Medicine
Bhagat, M., Kamal, R., Sharma, J., Kaur, K., Sharma, A. K., Singh, T. G., Bhatia, R., & Awasthi, A. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-03010-6 · Cited by 14 · see citing works
Advanced nanomaterial for prostate cancer theranostics
Hao, B., Li, W., Cheng, Y., Ma, Z., & Wang, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1046234 · Cited by 14 · see citing works
Nanotechnology-based drug delivery strategies for cancer therapy
Xu, Y., Ren, X., Yu, M., Weng, Y., Liu, Y., Song, B., Niu, J., Qiao, Z., Lin, Y., Cao, Y., et al. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0802 · Cited by 14 · see citing works
Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions
Man, H. S. J., Moosa, V. A., Singh, A. N., Wu, L., Granton, J. T., Juvet, S., Hoang, C. D., & de Perrot, M. E. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1281538 · Cited by 14 · see citing works
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
Hadi, R., Poddar, A., Sonnaila, S., Bhavaraju, V. S. M., & Agrawal, S. (2024) · Cells · doi:10.3390/cells13211794 · Cited by 14 · see citing works
Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives
Sala, V., Cnudde, S., Murabito, A., Massarotti, A., Hirsch, E., & Ghigo, A. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113191 · Cited by 13 · see citing works
Kong, H., Yang, G., He, P. L., Zhu, D., Luan, X., Xu, Y., Mu, R., & Wei, G. (2023) · Nano Futures · doi:10.1088/2399-1984/acafbe · Cited by 13 · see citing works
Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells
Zakeri‐Milani, P., Shirani, A., Nokhodchi, A., Farkhani, S. M., Mohammadi, S., Mojarrad, J. S., Mahmoudian, M., Gholikhani, T., Farshbaf, M., & Valizadeh, H. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1734017 · Cited by 13 · see citing works
Rescue from Pseudomonas aeruginosa Airway Infection via Stem Cell Transplantation
Brinkert, K., Hedtfeld, S., Burhop, A., Gastmeier, R., Gad, P., Wedekind, D., Kloth, C., Rothschuh, J., Lachmann, N., Hetzel, M., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.003 · Cited by 12 · see citing works
Puig-Rigall, J., Blanco‐Prieto, M. J., Aydillo, C., Rădulescu, A., Molero, D., Dreiss, C. A., & González‐Gaitano, G. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.114930 · Cited by 12 · see citing works
Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer
Zhang, S., Chen, M., Geng, Z., Liu, T., Li, S., Yu, Q., Cao, L., & Liu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317056 · Cited by 11 · see citing works
Ultra-Confined Controllable Cyclic Peptides as Supramolecularbiomaterials
Chorsi, M. T., Linthicum, W., Pozhidaeva, A., Mundrane, C., Mulligan, V. K., Chen, Y., Tavousi, P., Gorbatyuk, V., Vinogradova, O., Hoch, J. C., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2024.102247 · Cited by 11 · see citing works
CRISPR use in diagnosis and therapy for COVID-19
Deol, P., Madhwal, A., Sharma, G., Kaushik, R., & Malik, Y. S. (2022) · Methods in microbiology · doi:10.1016/bs.mim.2022.03.002 · Cited by 11 · see citing works
Virus-inspired lipopeptide-derived nucleic acid delivery to cartilage for osteoarthritis therapy
Fu, Y., Huang, Y., Wang, Y., Fu, Z., Cai, W., Wang, L.-Y., Wu, Y., Zhou, X., Ma, Z., Xu, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64212-5 · Cited by 10 · see citing works
Lung-targeted RNA delivery systems: strategies and therapeutic applications
Xu, S., Li, M., Wang, T., Chen, R., Zhou, M., Tang, Z., Liu, Q., Hu, L., & Li, Z. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-04019-0 · Cited by 10 · see citing works
Zhang, Y., Shen, J., Xu, Y., Feng, F., Han, X., Xi, K., Fang, Z., Zhang, Y., Wang, M., Wang, Z., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2025.12.014 · Cited by 10 · see citing works
Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapies
Khazaei, S., Varela‐Calviño, R., Rad‐Malekshahi, M., Quattrini, F., Jokar, S., Rezaei, N., Balalaie, S., Haririan, I., Csaba, N., & García-Fuentes, M. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01410-y · Cited by 10 · see citing works
Cunha, J., Ventura, F. V., Charrueau, C., & Ribeiro, A. J. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2405207 · Cited by 10 · see citing works
From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies
Xu, L., Li, C., Liao, R., Xiao, Q., Wang, X., Zhao, Z., Zhang, W., Ding, X., Cao, Y., Cai, L., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00863 · Cited by 10 · see citing works
Peptide Nanoparticles for Gene Packaging and Intracellular Delivery
Vila-Gómez, P., Noble, J. E., & Ryadnov, M. G. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0928-6_3 · Cited by 9 · see citing works
Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics
Banerjee, A., Mukherjee, S., & Maji, B. K. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211008106 · Cited by 9 · see citing works
Self-Assembly of Peptide–Lipid Nanoparticles for the Efficient Delivery of Nucleic Acids
Zhang, J., Wang, Z., Min, J., Zhang, X., Su, R., Wang, Y., & Qi, W. D. (2023) · Langmuir · doi:10.1021/acs.langmuir.3c00834 · Cited by 8 · see citing works
Kong, N., Chen, D., Wu, B., Liang, J., Zhou, Z., Lu, H., Li, Y., Zhang, P., Liu, H., & Wang, H. (2025) · Science Advances · doi:10.1126/sciadv.ady0952 · Cited by 8 · see citing works
Non‐Viral Nucleic Acid Delivery System for RNA Therapeutics
Liu, L., Zhou, Y., Xu, A., Wang, C., Li, N., Huang, H., Zhang, Y., & Yang, X. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300005 · Cited by 7 · see citing works
Progress in understanding the molecular pathology and microbiology of cystic fibrosis
Tümmler, B. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30333-9 · Cited by 7 · see citing works
Brokmann, F., Luthe, K., Hartmann, J., Müller, L., Klammt, F., Hoffmann, C., Weitschies, W., & Rosenbaum, C. (2025) · Pharmaceuticals · doi:10.3390/ph18030310 · Cited by 6 · see citing works
Recent strategies for enhanced delivery of mRNA to the lungs
Heiser, B. J., Veyssi, A., & Ghosh, D. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2485669 · Cited by 6 · see citing works
Zhao, Y., Wich, D., & Xu, Q. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00793 · Cited by 6 · see citing works
Liang, Y., Tan, X., Yang, Y. R., Zhang, J., Gao, X., Yin, M., Gao, H., Yang, S. X., & Zhang, K. (2025) · Nano Research · doi:10.26599/nr.2025.94907874 · Cited by 5 · see citing works
Liu, S., Deng, S., Li, M., Chen, J., Yuan, Y., Zhao, H., Zhou, J., Wang, J., Zhang, H., & Cheng, D. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c16588 · Cited by 5 · see citing works
Fan, X., Jiang, K., Zhao, Y., Lee, B. T., Geng, F., Brelen, M. E., Lu, W., & Wei, G. (2025) · Advanced Science · doi:10.1002/advs.202410744 · Cited by 5 · see citing works
Design of peptide-based gene delivery systems to overcome biological barriers
Wang, Z., Zhou, J., Su, R., Qi, W. D., & Wang, Y. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00766f · Cited by 4 · see citing works
Zhao, J., Yin, T., Deng, Y., Liu, H., Wei, M., Chu, C., Liang, X., Bi, X., He, H., Gou, J., et al. (2026) · Science Advances · doi:10.1126/sciadv.adw7275 · Cited by 4 · see citing works
Li, J., Wei, J., Gao, Y., Zhao, Q., Sun, J., Ouyang, J., & Na, N. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.07.005 · Cited by 4 · see citing works
Pulmonary Delivery of Messenger RNA (mRNA) Therapeutics for Respiratory Diseases
Qiu, Y., Chow, M. Y. T., & Lam, J. K. W. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_7 · Cited by 4 · see citing works
Chen, D., Kong, N., & Wang, H. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200113 · Cited by 4 · see citing works
Maurya, S., Srivastava, R., Arfin, S., Hawthorne, S. J., Jha, N. K., Agrawal, K., Raj, S., Rathi, B., Kumar, A. J., Raj, R., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0437 · Cited by 4 · see citing works
Peptide Self-Assembly Facilitating DNA Transfection and the Application in Inhibiting Cancer Cells
Wang, J., Ye, M., & Zhu, B. (2024) · Molecules · doi:10.3390/molecules29050932 · Cited by 3 · see citing works
Polymeric and Inorganic Nanoparticles Targeting Chronic Respiratory Diseases
Chan, Y., Ng, S. W., & Soon, L. (2022) · Springer eBooks · doi:10.1007/978-981-16-4392-7_18 · Cited by 3 · see citing works
- Authors
- Guan, S., Munder, A., Hedtfeld, S., Braubach, P., Glage, S., Zhang, L., Lienenklaus, S., Schultze, A., Hasenpusch, G., Garrels, W., Stanke, F., Miskey, C., Johler, S. M., Kumar, Y., Tümmler, B., Rudolph, C., Ivics, Z., & Rosenecker, J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Medizinische Hochschule Hannover (DE)
- Ethris (Germany) (DE)
- Paul Ehrlich Institut (DE)
- GATC Biotech (Germany) (DE)
- Corresponding author
- Rosenecker, Joseph
- ORCID
- Venue
- Nature Nanotechnology
- Published
- 2019-01-28
- Volume
- 14
- Issue
- 3
- Pages
- 287-297
- ISSN
- 1748-3387 (ISSN-L)
- 1748-3395
- OpenAlex
- W2914518223
- Cited by
- 130
- References
- 51
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 19 · 2023: 19 · 2022: 21 · 2021: 13 · 2020: 16 · 2019: 10
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Nanotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- cystic fibrosis, poloxamine, self-assembly, non-viral gene delivery, gene therapy, CFTR, plasmid transfection, mRNA delivery, integrating vectors, in vivo transfection, lung gene delivery
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Cystic Fibrosis, Ethylenediamines, Gene Expression Regulation, Humans, Luciferases, Peptides, RNA, Messenger, Genome, Genes, Reporter, Cystic Fibrosis Transmembrane Conductance Regulator, Transgenes, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review